Trials / Withdrawn
WithdrawnNCT06427512
Mechanisms Underlying Cardiovascular Consequences Associated With COVID-19 and Long COVID
Mechanisms Underlying Cardiovascular Consequences Associated With COVID-19 and Long COVID - Characterizing Long COVID Phenotypes Using Physiological and Molecular Studies
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Columbia University · Academic / Other
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- —
Summary
AIM 1. Characterize cardiovascular phenotypes of long COVID by cardiopulmonary, meta-bolic, and cardiac mechanical/physiological responses to exercise and microvascular vasomotor function. AIM 2. Identify intercellular signaling between immune cells and cardiac cells associated with microvascular phenotypes of long COVID.
Detailed description
As many as 40-60% of patients who recovered from mild or moderate acute COVID have reported what is now called long COVID - multiple, persistent or recurrent symptoms lasting 6-9 months (or longer) following initial illness.1-4 Fatigue, dyspnea, and chest pain are the most common symptoms. Others include palpitations, lightheadedness, and syncope. All these cardiovascular symptoms can be debilitating, resulting in worse quality of life and morbidity.5, 6 Treatment options are limited.
Conditions
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2024-05-24
- Last updated
- 2024-05-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06427512. Inclusion in this directory is not an endorsement.